Android app on Google Play

Celldex Therapeutics (CLDX) Tops Q2 Loss Views by 2c/Share

August 10, 2012 7:01 AM EDT Send to a Friend
Get Alerts CLDX Hot Sheet
Trade CLDX Now!
Join SI Premium – FREE
Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment